This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Actual results may differ materially from the results expressed or implied in these statements as a result of risks, uncertainties, and other factors, including, but not limited to, the factors set forth in the company's filings with the Securities and ExchangeCommission, which can be found on the company's website, or at sec.gov.
Actual results may differ materially from the results expressed or implied in these statements as a result of risks, uncertainties and other factors, including, but not limited to, the factors set forth in the company's filings with the Securities and ExchangeCommission, which can be found on the company's website or at sec.gov.
You should be aware that prepared remarks today made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. And although the current economic climate is challenging, it presents an excellent opportunity for off-price deal-making with distressed vendors and retailers.
See 3 “Double Down” stocks » *Stock Advisor returns as of November 4, 2024 For a complete discussion of the risks and uncertainties related to our business, please refer to the information contained in our filings with the Securities and ExchangeCommission as well as today's earnings please.
During this call, we may make certain statements related to our business that are forward-looking statements under federal securities laws. As a result, the board has appointed a special committee to evaluate any proposed [Technical difficulty] in light of the company's strategic options in the best interest of shareholders.
Earlier today, we published a shareholder letter and press release with our financial results and commentary for our first quarter of fiscal year 2025. As always, our shareholder letter contains management's insight and commentary for the quarter. And I would just point out, deal timing was not a factor in Q1 as it was in Q4.
Actual results may differ materially from those in forward-looking statements as a result of a number of factors, including those described from time to time in Blue Owl Capital's filings with the Securities and ExchangeCommission. This robust growth has allowed us to return significant capital to our shareholders.
Our Form 10-K for the 2022 fiscal year and our subsequent filings with the Securities and ExchangeCommission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K, are available on our website.
The matters discussed in today's conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including projections, estimates and descriptions of future events. Securities and ExchangeCommission. We'll move fast. Turning to S&P Dow Jones Indices.
See 3 “Double Down” stocks » *Stock Advisor returns as of November 18, 2024 Factors that may cause such a difference include, but are not limited to, those described in the company's filings with the Securities and ExchangeCommission. We also signed several new deals for Nanox.AI FDA for Nanox.AI Health CNG version 2.0,
During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Of note, cash flow excluding the purchase of marketable securities used approximately $130 million for all of 2023.
Actual results may differ materially from those in forward-looking statements as a result of a number of factors, including those described from time to time in Blue Owl Capital's filings with the Securities and ExchangeCommission. Similarly, Atalaya and our credit teams have been active in sourcing investment-grade flow.
The matters discussed in today's conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including projections, estimates and descriptions of future events. Learn more *Stock Advisor returns as of February 7, 2025 Securities and ExchangeCommission.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content